Dudediligence.

Anavex Life Sciences Corp

AVXLNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 288-KChange in control and shareholder vote5.015.07
  2. Sep 98-KOther events8.01
  3. Sep 28-KOther events8.019.01
  4. Aug 2810-QQuarterly report
  5. Aug 2810-QQuarterly report
  6. Aug 258-KResults of operations2.029.01
  7. Aug 178-KRegulation FD disclosure7.019.01
  8. Aug 118-KRegulation FD disclosure7.019.01
  9. Aug 38-KRegulation FD disclosure7.019.01
  10. Jul 3113GPassive stake of 5% or more (13G), filed by Vanguard Capital Management
  11. Jul 308-KResults of operations2.029.01
  12. Jul 208-KOther events8.01
  13. Jun 268-KOther events8.01
  14. May 228-KOther events and listing notice or transfer3.018.019.01
  15. May 158-KOfficer or director change5.02
  16. May 68-KOfficer or director change5.029.01
  17. Mar 258-KOther events8.019.01
  18. Feb 258-KOfficer or director change and Regulation FD disclosure5.027.019.01
  19. Feb 910-QQuarterly report
  20. Feb 98-KResults of operations2.029.01
  21. Nov 25, 202510-KAnnual report
  22. Nov 25, 20258-KResults of operations2.029.01
  23. Nov 14, 20258-KOther events8.019.01
  24. Aug 12, 202510-QQuarterly report
  25. Jul 25, 20258-KMaterial agreement1.019.01
  26. Jul 25, 2025424B5Prospectus for an offering
  27. Jul 14, 2025S-3Shelf registration
  28. Jul 3, 20258-KOfficer or director change5.029.01
  29. Jun 13, 20258-KOfficer or director change and shareholder vote5.025.079.01
  30. May 13, 202510-QQuarterly report
  31. Feb 12, 202510-QQuarterly report
  32. Dec 23, 202410-KAnnual report